Skip to main content

UBS Group AG

Position in JBIO — Jade Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in JBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,834,759
+$1,921,201 QoQ
Shares Held
127,577
+96.2% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 153 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in JBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. JBIO ranks #185 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JBIO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,834,759 127,577
2026-03-31 $913,558 65,022
2025-12-31 $1,493,407 96,786
2025-09-30 $171,141 19,831
2025-06-30 $210,169 21,038
2025-03-31 AVTE 8,830
2024-12-31 AVTE 9,553
2024-09-30 AVTE 6,344
2024-06-30 AVTE 11,052
2024-03-31 AVTE 11,237
2023-12-31 AVTE 12,241
2023-09-30 AVTE 11,214
2023-06-30 AVTE 2,999
2023-03-31 AVTE 5,986
2022-09-30 AVTE 1,612
2021-12-31 AVTE 484
2021-09-30 AVTE 1,091
2021-06-30 AVTE 2,050